Maclusa Tablet combines Sofosbuvir/Velpatasvir, a direct-acting antiviral therapy used to treat Hepatitis C infection. It works by stopping the replication of the Hepatitis C virus in the liver, helping to achieve a complete viral cure and improve liver function.

Uses

• Treatment of all genotypes of chronic Hepatitis C

• Reduces viral load in the bloodstream

• Prevents liver damage and cirrhosis

• Supports overall liver health and function

Benefits

• High cure rate for Hepatitis C patients

• Protects liver from long-term complications

• Easy oral administration with once-daily dosing

• Well-tolerated with minimal side effects under medical supervision

Dosage

• Typically 1 tablet daily, as prescribed by a doctor

• Taken with or without food

• Duration of therapy depends on viral genotype and patient condition